Epirizole structure
|
Common Name | Epirizole | ||
|---|---|---|---|---|
| CAS Number | 18694-40-1 | Molecular Weight | 234.25400 | |
| Density | 1.25g/cm3 | Boiling Point | 444ºC at 760mmHg | |
| Molecular Formula | C11H14N4O2 | Melting Point | 90 - 92ºC | |
| MSDS | Chinese USA | Flash Point | 222.3ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of EpirizoleEpirizole (Mepirizole) is an orally active NSAID (nonsteroidal anti-inflammatory drug). Epirizole shows anti-inflammatory activity, and can be used in chronic rheumatoid arthritis research[1]. |
| Name | 4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine |
|---|---|
| Synonym | More Synonyms |
| Description | Epirizole (Mepirizole) is an orally active NSAID (nonsteroidal anti-inflammatory drug). Epirizole shows anti-inflammatory activity, and can be used in chronic rheumatoid arthritis research[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Epirizole (1-1000 μM; 24 h) increases MDR1 mRNA expression in Caco-2 cells[1]. RT-PCR[1] Cell Line: Caco-2 cells Concentration: 1, 10, 100, and 1000 μM Incubation Time: 24 hours Result: Increased the level of MDR1 mRNA expression. |
| Density | 1.25g/cm3 |
|---|---|
| Boiling Point | 444ºC at 760mmHg |
| Melting Point | 90 - 92ºC |
| Molecular Formula | C11H14N4O2 |
| Molecular Weight | 234.25400 |
| Flash Point | 222.3ºC |
| Exact Mass | 234.11200 |
| PSA | 62.06000 |
| LogP | 1.29630 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.601 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H312-H315-H319-H332-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful; |
| Risk Phrases | R20/21/22;R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | UV9290000 |
| HS Code | 2933990090 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation.
Proc. Natl. Acad. Sci. U. S. A. 108(48) , 19264-9, (2011) Pancreatic β-cells are an essential source of insulin and their destruction because of autoimmunity causes type I diabetes. We conducted a chemical screen to identify compounds that would induce the d... |
|
|
Role of active oxygen species and lipid peroxidation in mepirizole-induced duodenal ulcers in rats.
Dig. Dis. Sci. 43(8) , 1657-64, (1998) The role of active oxygen species and lipid peroxidation in the pathogenesis of duodenal ulcers induced by mepirizole was investigated in rats. Oral administration of mepirizole (200 mg/kg) resulted i... |
|
|
Tobacco cigarette smoke attenuates duodenal ulcer margin hyperemia in the rat. Comparison of IAP clearance and hydrogen gas clearance techniques for measurements of gastrointestinal blood flow.
Dig. Dis. Sci. 40(5) , 1112-7, (1995) The hyperemia at the duodenal ulcer margin is important for ulcer healing. We studied the effect of tobacco cigarette smoke on the hyperemia at the margin of mepirizole-induced duodenal ulcer. Duodena... |
| Mebron |
| Epirizolum [INN-Latin] |
| Mepirizole |
| Mepirizol [German] |
| 4-methoxy-2-(5-methoxy-3-methyl-pyrazol-1-yl)-6-methyl-pyrimidine |
| 1-(4-Methyl-6-methoxy-pyrimidin-2-yl)-3-methyl-5-methoxy-pyrazol |
| DA-398 |
| Methopyrimazole |
| 4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine |
| Epirizol [INN-Spanish] |
| EINECS 242-507-1 |
| epirizole |
| MFCD00057351 |
| 1-(4-Methoxy-6-methyl-2-pyrimidinyl)-3-methyl-5-methoxy-pyrazol |